Lidocaine Hydrochloride and Epinephrine

Product NDC: 61699-3178
11-digit product format: 616993178
Labeler code: 61699
Product ID: 61699-3178_18c4753b-0899-4d27-beff-65b5e4aaff02
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: LIDOCAINE HYDROCHLORIDE ANHYDROUS and EPINEPHRINE
Dosage form: INJECTION, SOLUTION
Route: INFILTRATION
Labeler: US MedSource, LLC
Application: ANDA089644
Marketing category: ANDA
Marketing start: 2014-06-12
Marketing end: 0000-00-00
Substance: LIDOCAINE HYDROCHLORIDE ANHYDROUS; EPINEPHRINE
Active strength: 10 mg/mL; ug/mL
Pharmacologic classes: Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	61699-3178		I	Inactivated by FDA		2026-08-03
excluded package	package	61699-3178	61699-3178-3	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61699-3178-3	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61699-3178-3	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61699-3178-3	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61699-3178-3	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61699-3178-3	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61699-3178-3	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61699-3178-3	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61699-3178-3	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61699-3178-3	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61699-3178-3	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61699-3178-3	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61699-3178-3	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	61699-3178-3	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	61699-3178-3	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	61699-3178-3	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	61699-3178-3	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	61699-3178-3	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	61699-3178-3	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	61699-3178-3	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	61699-3178-3	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	61699-3178-3	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	61699-3178-3	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	EPINEPHRINE; LIDOCAINE HYDROCHLORIDE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP		1988-06-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A089644-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A089644-001	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	0.01MG/ML;1%	INJECTABLE / INJECTION	AP	1988-06-21	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A089644-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A089644-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A089644-001	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A089644-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A089644-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A089644-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A089644-001	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A089644-001	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A089644-001	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A089644-001	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A089644-001	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A089644-001	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A089644-001	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A089644-001	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A089644-001	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A089644-001	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A089644-001	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A089644-001	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A089644-001	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A089644-001	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A089644-001	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A089644-001	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A089644-001	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A089644-001	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A089644-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A089644-001	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A089644-001	AP	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A089644-001	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A089644-001	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A089644-001	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A089644-001	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A089644-001	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A089644-001	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A089644-001	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A089644-001	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A089644-001	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A089644-001	AP	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A089644-001	AP	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A089644-001	AP	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A089644-001	AP	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
070fbed5-7088-434a-a7ce-f2a64d8d40ac	Product name	2	20260107
0b4ec9ca-d305-43fc-88dd-7a510313efe0	Product name	1	20260105
bb209f42-a85f-4fee-9d3d-c9dded168625	Product name	1	20251208
49628fc7-2031-4c28-bd31-0ef3aa8f44a3	Product name	3	20251118
bee66ce1-adb7-9d3b-67d9-582e4c54e80f	Product name	5	20250819
cbf85893-59ef-423f-87d4-a573c000a8b9	Product name	8	20250731
b5b1095b-40cd-8a9e-b111-502545045b07	Product name	4	20250325
e190029e-423b-473c-8e04-2ada59b5b711	Product name	1	20250314
860a93dc-4863-49cc-b284-6bbe8191bc48	Product name	4	20250214
eaba870a-6a9d-442e-8643-87b3f558a451	Product name	1	20250117
e0031c74-3853-42bc-8e10-86dbbe83992e	Product name	2	20231116
f7046b89-2016-499a-adc6-78479172abc6	Product name	1	20230425
9b4cf230-fd05-41d5-98c6-5db9ecb27b86	Product name	1	20230117
7d755fa1-1087-4dcd-98f0-6d4bba479a57	Product name	3	20210602
aed701d5-9c75-dfaf-7154-cde46179faea	Product name	9	20200313
2686d634-e712-4007-8dbf-3d37c6c4d71f	Product name	1	20181121
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
bd49bb86-2d32-4a7a-a594-eeda2e29af42	Product name	1	20180118
332d03e4-aa24-4b11-841a-02bf41081920	Product name	1	20171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
3becbe78-12d9-4ad2-9b4c-1e36f8d1303a	Product name	1	20170815
68ed98f8-24c2-44a0-944a-6d36e82ce25a	Product name	1	20141222
1cd42bc2-a430-c72b-636d-991b235fbf80	Product name	1	20140508
49fa150c-f0de-cce7-3d9c-993ed81c5698	Product name	1	20140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ff	Product name	1	20140508
9137811f-f279-8640-5aeb-99fa2145d64d	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61699-3178-3	2019-11-27	C162847	48780-1	9855e2a2-4bf6-60a7-e053-dbdaa90a05bd	Lidocaine Hydrochloride and Epinephrine Injection, USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
61699-3178-3	Lidocaine Hydrochloride and Epinephrine	1 in 1 BAG	INJECTION, SOLUTION	1		1
61699-3178-3	Lidocaine Hydrochloride and Epinephrine	50 mL in 1 VIAL, MULTI-DOSE	INJECTION, SOLUTION	50		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
EPINEPHRINE	ACTIVE INGREDIENT	YKH834O4BH	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (LIDOCAINE HYDROCHLORIDE ANHYDROUS AND EPINEPHRINE) INJECTION, SOLUTION [US MEDSOURCE, LLC]	1
LIDOCAINE HYDROCHLORIDE ANHYDROUS	ACTIVE INGREDIENT	EC2CNF7XFP	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (LIDOCAINE HYDROCHLORIDE ANHYDROUS AND EPINEPHRINE) INJECTION, SOLUTION [US MEDSOURCE, LLC]	1
EPINEPHRINE	ACTIVE MOIETY	YKH834O4BH	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (LIDOCAINE HYDROCHLORIDE ANHYDROUS AND EPINEPHRINE) INJECTION, SOLUTION [US MEDSOURCE, LLC]	1
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (LIDOCAINE HYDROCHLORIDE ANHYDROUS AND EPINEPHRINE) INJECTION, SOLUTION [US MEDSOURCE, LLC]	1
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (LIDOCAINE HYDROCHLORIDE ANHYDROUS AND EPINEPHRINE) INJECTION, SOLUTION [US MEDSOURCE, LLC]	1
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (LIDOCAINE HYDROCHLORIDE ANHYDROUS AND EPINEPHRINE) INJECTION, SOLUTION [US MEDSOURCE, LLC]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (LIDOCAINE HYDROCHLORIDE ANHYDROUS AND EPINEPHRINE) INJECTION, SOLUTION [US MEDSOURCE, LLC]	1
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (LIDOCAINE HYDROCHLORIDE ANHYDROUS AND EPINEPHRINE) INJECTION, SOLUTION [US MEDSOURCE, LLC]	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (LIDOCAINE HYDROCHLORIDE ANHYDROUS AND EPINEPHRINE) INJECTION, SOLUTION [US MEDSOURCE, LLC]	1
SODIUM METABISULFITE	INACTIVE INGREDIENT	4VON5FNS3C	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (LIDOCAINE HYDROCHLORIDE ANHYDROUS AND EPINEPHRINE) INJECTION, SOLUTION [US MEDSOURCE, LLC]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (LIDOCAINE HYDROCHLORIDE ANHYDROUS AND EPINEPHRINE) INJECTION, SOLUTION [US MEDSOURCE, LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61699-3178	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (LIDOCAINE HYDROCHLORIDE ANHYDROUS AND EPINEPHRINE) INJECTION, SOLUTION [US MEDSOURCE, LLC]	1	Legacy NDC, 2 package rows	20140618_96773b3d-3eed-4bc9-aac0-18c185377cad.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
LIDOCAINE HCI	LIDOCAINE HCI	HF Acquisition Co LLC, DBA HealthFirst	76176d50-a987-c9f9-e053-2991aa0aea0f	2026-06-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089644 application number: ANDA089644
Lidocaine Hydrochloride and Epinephrine	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	Hospira, Inc.	2f94f711-14c4-48ec-c5a3-c5ec4b8e8729	2026-06-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089644 application number: ANDA089644
Lidocaine Hydrochloride and Epinephrine	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	Henry Schein, Inc.	27194739-3382-46b0-94cd-096531345325	2026-06-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089644 application number: ANDA089644
Lidocaine Hydrochloride and Epinephrine	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	Cardinal Health 107, LLC	77fd6ee4-108f-4525-8df5-7db9236042ee	2026-05-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089644 application number: ANDA089644
Lidocaine Hydrochloride and Epinephrine	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	Sportpharm LLC	2c58deba-dbb2-4e73-a173-36053536f03e	2026-04-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089644 application number: ANDA089644
Lidocaine Hydrochloride and Epinephrine	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	Henry Schein, Inc.	c3490a23-14c4-43f7-b066-96a4c4298fde	2026-04-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089644 application number: ANDA089644
LIDOCAINE HCI	LIDOCAINE HCI	HF Acquisition Co LLC, DBA HealthFirst	95309440-34ec-11fe-e053-2a95a90a1c90	2025-06-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089644 application number: ANDA089644
LIDOCAINE HCI AND EPINEPHRINE	LIDOCAINE HCI AND EPINEPHRINE	HF Acquisition Co LLC, DBA HealthFirst	957506a5-1b09-0736-e053-2995a90a0b63	2024-02-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089644 application number: ANDA089644

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
EC2CNF7XFP	LIDOCAINE HYDROCHLORIDE ANHYDROUS	73-78-9	LIDOCAINE HYDROCHLORIDE ANHYDROUS
YKH834O4BH	EPINEPHRINE	51-43-4	EPINEPHRINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1010751	lidocaine HCl 1 % / EPINEPHrine 1:100,000 Injectable Solution	PSN	96773b3d-3eed-4bc9-aac0-18c185377cad	1
1010751	epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution	SCD	96773b3d-3eed-4bc9-aac0-18c185377cad	1
1010751	epinephrine (as epinephrine bitartrate) 1:100,000 / lidocaine hydrochloride 1 % Injectable Solution	SY	96773b3d-3eed-4bc9-aac0-18c185377cad	1
1010751	lidocaine HCl 1 % / EPINEPHrine 1:100,000 Injectable Solution	SY	96773b3d-3eed-4bc9-aac0-18c185377cad	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
61699-3178-3	61699317803	1 in 1 BAG	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Lidocaine Hydrochloride and Epinephrine Injection, USP	US MedSource, LLC	2014-06-10	HUMAN PRESCRIPTION DRUG LABEL	1